Skip to Content
Merck
CN

Key Documents

View All Documentation

130532

5,7-Dichloro-8-hydroxy-2-methylquinoline

98%

Synonym(s):

5,7-Dichloro-2-methyl-8-quinolinol, 5,7-Dichloro-8-hydroxyquinaldine, 5,7-Dichloro-8-quinaldinol, BCM

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C10H7Cl2NO
CAS Number:
72-80-0
Molecular Weight:
228.07
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
24847966
EC Number:
200-789-3
Beilstein/REAXYS Number:
156683
MDL number:
MFCD00023984
Assay:
98%
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

200

assay

98%

mp

108-112 °C (dec.) (lit.)

functional group

chloro

SMILES string

Cc1ccc2c(Cl)cc(Cl)c(O)c2n1

InChI

1S/C10H7Cl2NO/c1-5-2-3-6-7(11)4-8(12)10(14)9(6)13-5/h2-4,14H,1H3

InChI key

GPTXWRGISTZRIO-UHFFFAOYSA-N

pictograms

Exclamation mark
GHS07

signalword

Warning

hcodes

H302

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCL9893
BCCJ5523
BCCF7602
BCCC6368
BCBX0666

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A double-blind comparative study to compare the efficacy of Locoid C with Tri-Adcortyl in children with infected eczema.
F O Meenan
The British journal of clinical practice, 42(5), 200-202 (1988-05-01)
I Corrihons et al.
Pathologie-biologie, 39(2), 136-139 (1991-02-01)
The activity of chlorquinaldol, a derivative of hydroxy-8-quinolein used for local antisepsy, was studied against Neisseria gonorrhoeae and Chlamydia trachomatis. The weak solubility of the product and the special growth conditions of the organisms made an adaptation of the AFNOR
[Therapeutic efficacy of the combination of chlorquinaldol plus promestriene in infections of the vagina].
S Palacios Gil-Antuñano
Revista clinica espanola, 173(5-6), 297-300 (1984-06-15)
View All Related Papers

Global Trade Item Number

SKUGTIN
130532-10G04061838727534